AI & Machine Learning
Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna…
- Drug Discovery and Delivery
- CRISPR
- Biotech
- Website
- algenbio.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 11-50 people
- Founded
- 2020
- Demo
- 20 min demo
Similar companies
Adventris PharmaceuticalsAdventris makes cancer vaccines
Parallel BioUsing the immune system to cure disease
Arpeggio BioArpeggio Bio develops drugs targeting transcription factors using AI…
Avro Life ScienceSkin patches for generic drug delivery.
General ProximityThe next generation of induced-proximity medicines.
Harmonic DiscoveryMulti-targeted therapeutics to treat complex diseases
Yemaachi BiotechnologyDiversifying precision cancer diagnostics and treatments
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.